ANNA MAZUR: Open Payments
NPI 1225769326 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,660 in 207 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $327 · 2025 $3,660
Food & beverage: $3,660
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 49 | $861 |
| Takeda Pharmaceuticals U.S.A., Inc. | 30 | $570 |
| GENZYME CORPORATION | 18 | $351 |
| Aimmune Therapeutics, Inc. | 20 | $259 |
| Janssen Biotech, Inc. | 12 | $234 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 17 | $230 |
| Ardelyx, Inc. | 11 | $216 |
| Madrigal Pharmaceuticals | 11 | $170 |
| Ipsen Biopharmaceuticals, Inc | 10 | $160 |
| Celltrion USA Inc. | 6 | $121 |
Products named: ENTYVIO, DUPIXENT, RINVOQ, TREMFYA, SKYRIZI, IBSRELA, XIFAXAN, ZENPEP.
Industry payments across OH — which companies pay providers there.
